The Juvederm product family consists of five FDA-approved fillers utilizing Hylacross cross-linking technology to address specific facial areas at Enfield Royal Med Spa Viera,FL dermatology practices. This hyaluronic acid filler collection provides non-surgical solutions for volume loss, deep folds, and lip refinement with results lasting between 12 and 24 months. According to the American Society of Plastic Surgeons (2024), 5.3 million total HA filler procedures are carried out across the USA. Melbourne, Viera, and Rockledge residents utilize these specific formulations to counteract Florida photoaging and age-related midface volume deficit. This guide details the clinical specifications, duration, and patient satisfaction rates for Juvederm Ultra XC, Juvederm Voluma XC, Juvederm Volbella XC, and Juvederm Vollure XC to assist patients in selecting the appropriate treatment for their aesthetic and aging reversing goals. Our clinic located in the heart of Viera, Florida, providing dermal fillers treatment for the residents of melbourne, fillers for facial rejvenation in Rockledge and injectable fillers for Viera & Suntree.
Juvederm is a collection of five FDA-approved hyaluronic acid fillers using Hylacross technology to provide facial volume, wrinkle reduction, and lip enhancement. According to FDA approval documentation (2006, 2013, 2016, 2017), the Juvederm product family utilizes cross-linked hyaluronic acid to replace lost subcutaneous volume. Allergan manufactures the Juvederm product family with 0.3% lidocaine to increase patient comfort during injection.
The Juvederm product family includes:
According to Journal of Cosmetic Dermatology research (2020), Hylacross cross-linking technology provides firmer consistency than competitor HA fillers while maintaining an 8.4 G-prime across the product line. This technology allows the gel to resist degradation from natural hyaluronidase. Juvederm product family fillers remain fully reversible using injected hyaluronidase if removal is required for medical or aesthetic reasons.
Juvederm Ultra XC treats lip augmentation and moderate facial wrinkles with 12-month duration and 96% patient satisfaction. According to Allergan clinical trials (2021, N=205), Juvederm Ultra XC provides lip volume enhancement persisting through 52-week follow-up periods with measurable improvement.
Juvederm Ultra XC contains 24 mg/mL hyaluronic acid concentration, injected at mid-dermal depth. Board-certified injectors in Melbourne, FL administer Juvederm Ultra XC in three primary areas:
Juvederm Ultra XC received FDA approval in 2006 for moderate facial wrinkles and lip augmentation indications. Juvederm Ultra XC’s smooth gel consistency differentiates Juvederm Ultra XC from granular competitor formulations, providing even distribution across injection sites. Compare Juvederm vs Restylane; which filler is right for you?.
Juvederm Voluma XC restores cheek volume with 24-month duration, representing the longest-lasting FDA-approved hyaluronic acid filler for midface augmentation. According to FDA pivotal trial data (2013, N=265), Juvederm Voluma XC maintains 75% of initial volume at 2-year follow-up with 92% patient satisfaction ratings.
Juvederm Voluma XC contains 20 mg/mL hyaluronic acid concentration with subcutaneous/supraperiosteal injection depth for optimal cheek lifting. Treatment of both cheeks requires 1-2 syringes (2-4 mL total volume) of Juvederm Voluma XC per session.
Melbourne patients with Florida photoaging experience accelerated midface volume loss, making Juvederm Voluma XC valuable for Brevard County cheek restoration. Juvederm Voluma XC’s 24-month duration exceeds Juvederm Ultra XC’s 12-month timeline and competitor products averaging 12-18 months.
Juvederm Voluma XC received FDA approval in 2013 specifically for cheek augmentation and age-related midface volume deficit in patients over 21 years.
Juvederm Voluma before/after cheek augmentation showing midface lift]
Juvederm Volbella XC treats lip augmentation and perioral lines with 12-month duration and 89% patient satisfaction. According to Allergan clinical data (2016, N=168), Juvederm Volbella XC achieves 63% improvement in vertical lip line severity at 12-month follow-up assessment.
Juvederm Volbella XC contains 15 mg/mL hyaluronic acid—the lowest concentration in the Juvederm product family, creating subtle, natural-feeling lip enhancement. Juvederm Volbella XC injection occurs at superficial dermal depth for perioral lines and vermillion border definition.
Treatment volumes for Juvederm Volbella XC include:
Juvederm Volbella XC received FDA approval in 2016 for lip augmentation and correction of perioral rhytids. Viera and Rockledge patients seeking subtle lip definition select Juvederm Volbella XC over Juvederm Ultra XC for refined outcomes.
Juvederm Vollure XC targets moderate-to-severe nasolabial folds with 18-month duration, providing 6 months longer correction than Juvederm Ultra XC. According to FDA clinical trials (2017, N=200), Juvederm Vollure XC achieves 79% improvement on the Wrinkle Severity Rating Scale at 18-month evaluation.
Juvederm Vollure XC uses Vycross technology—a modified version of Hylacross cross-linking—creating intermediate gel viscosity optimized for dynamic facial areas. Juvederm Vollure XC contains 17.5 mg/mL hyaluronic acid concentration with mid-to-deep dermal injection depth.
Juvederm Vollure XC treats Grade 3-4 nasolabial fold severity using 0.5-1.0 mL per fold. Juvederm Vollure XC received FDA approval in 2017 specifically for moderate-to-severe facial wrinkles and nasolabial folds.
Melbourne patients comparing Juvederm Vollure XC to Juvederm Ultra XC gain 6-month duration advantage: Juvederm Vollure XC provides 18 months versus Juvederm Ultra XC’s 12 months for nasolabial fold treatment.
Juvederm products differ by hyaluronic acid concentration (15-24 mg/mL), injection depth, and approved treatment duration while sharing identical 8.4 G-prime cross-linking density. According to Journal of Cosmetic Dermatology research (2020), Hylacross cross-linking technology provides 30% firmer gel consistency than competitor hyaluronic acid fillers.
The table below compares five Juvederm product specifications across key clinical attributes:
Product selection depends on treatment area, desired duration, and anatomical goals. All Juvederm products use identical Hylacross technology at 8.4 G-prime; hyaluronic acid concentration variation enables smooth cohesive gel performance across injection depths from superficial dermis to subcutaneous tissue.
Juvederm filler costs in Melbourne, FL range from $700-$900 per syringe depending on product selection and treatment complexity. According to ASPS 2024 data, the national average hyaluronic acid filler cost equals $683 per syringe.
Melbourne Juvederm pricing by product:
Cost-per-month analysis: Juvederm Voluma XC at $875 over 24 months equals $36/month; Juvederm Ultra XC at $725 over 12 months equals $60/month. Brevard County practices accept CareCredit financing (0% interest 6-12 months), LendingUSA payment plans ($50/month), and HSA/FSA funds for qualified treatments.
Melbourne patients select Juvederm products based on six decision factors: treatment area, volume needed, timeline expectations, facial movement zones, tissue thickness, and budget. According to Enfield Royal Med Spa clinical data (2023), 42% of Brevard County patients use multi-product treatments combining 2-3 Juvederm formulations.
Product recommendations by concern:
Space Coast patients benefit from board-certified injector consultation to evaluate facial anatomy, aging patterns, and treatment goals. Enfield Royal Med Spa (5460 Village Dr, Rockledge, FL 32955) provides a comprehensive Juvederm assessment for Melbourne, Viera, and Rockledge residents seeking individualized product selection. Schedule your Juvederm consultation
The Juvederm product family provides five FDA-approved hyaluronic acid fillers with Hylacross cross-linking technology, each optimized for specific facial areas from lips to midface. Melbourne dermatology practices offer all five formulations: Juvederm Ultra XC (lips), Juvederm Voluma XC (cheeks), Juvederm Volbella XC (perioral lines), Juvederm Vollure XC (nasolabial folds), and Juvederm Ultra Plus XC (severe folds).
Key selection criteria include treatment duration (12-24 months), hyaluronic acid concentration (15-24 mg/mL), and injection depth requirements for optimal outcomes. Brevard County residents in Melbourne, Viera, and Rockledge access comprehensive Juvederm consultations through board-certified injectors at Enfield Royal Med Spa.
Schedule a Juvederm consultation to determine optimal product selection for individualized facial rejuvenation goals. Contact Enfield Royal Med Spa to begin your assessment.
Let Us Know Where to Send Your Code
Valid once per new client. Expires in 30 day